肿瘤体积倍增时间小于1年与甲状腺髓样癌死亡风险较高相关
这项经机构审查委员会批准的队列研究纳入51例转移性甲状腺髓样癌患者,共286处转移灶、457次扫描,随访51个月(IQR 25-102)。基于最初3次和最后3次扫描计算的肿瘤体积倍增时间小于1年,以及肺、脑、前列腺为肿瘤生长最快的器官,是与较短疾病特异性生存独立相关的因素。基于二维和三维测量的肿瘤体积倍增时间强相关(r=0.94,P<.05)。
要点
- 转移性甲状腺髓样癌患者中,基于最初3次和最后3次扫描计算的肿瘤体积倍增时间小于1年与较短疾病特异性生存独立相关。
- 肺、脑、前列腺为肿瘤生长最快器官时,也与较短疾病特异性生存独立相关。
- 基于二维和三维测量的肿瘤体积倍增时间强相关(r=0.94,P<.05)。
核心结论
- 随访就诊前3次基线和3次最近扫描的测量可计算肿瘤体积倍增时间,并可作为甲状腺髓样癌死亡风险的预测因素。
研究设计与样本
- 经机构审查委员会批准的队列研究,纳入至少连续3次影像学检查的转移性甲状腺髓样癌患者。
- 研究样本为51例患者,共286处转移灶,通过457次扫描测量,随访51个月(IQR 25-102)。
- 中位年龄19岁(IQR 15-41),女性患者占53%。
主要发现
- 散发性甲状腺髓样癌患者全部转移灶的累积体积和肿瘤体积倍增时间小于1年的患者比例均高于遗传性甲状腺髓样癌患者(P<.01)。
- 基于最初3次和最后3次扫描的肿瘤体积倍增时间小于1年与较短疾病特异性生存独立相关。
- 肺、脑和前列腺为肿瘤生长最快器官与较短疾病特异性生存独立相关。
- 基于二维和三维测量的肿瘤体积倍增时间强相关(r=0.94,P<.05)。
临床怎么用
- 作者认为,基于随访就诊前3次基线和3次最近扫描的测量可计算肿瘤体积倍增时间,并可作为甲状腺髓样癌死亡风险的预测因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Tumor volume doubling time (TVDT) is emerging as a useful tool in predicting oncologic outcomes. There are limited data on the prognostic role of TVDT in metastatic medullary thyroid cancer (MTC). OBJECTIVE: The goal of this study was to assess the value of TVDT in predicting disease-specific survival (DSS) in patients with hereditary and sporadic MTC. METHODS: This was an Institutional Review Board-approved cohort study including patients with metastatic MTC having at least 3 consecutive imaging studies. TVDT of up to the 5 largest lesions per organ was calculated using a standardized formula. The association between TVDT and DSS was analyzed using Kaplan-Meier survival curves. Cox proportional regression model was used to account for confounding factors. RESULTS: The study sample consisted of 51 patients presenting with 286 metastatic lesions measured with 457 scans during the follow-up of 51 (IQR, 25-102) months. Median age was 19 years (IQR, 15-41), 53% female patients. Cumulative volumes of all metastatic lesions and proportion of patients with TVDT of < 1 year were higher in patients with sporadic as compared with hereditary MTC (P < .01). Factors independently associated with shorter DSS were TVDT of < 1 year based on 3 initial and 3 last scans as well as lung, brain, and prostate as the organs with the fastest growing tumor. TVDT based on 2-dimensional and 3-dimensional measurements showed strong correlation (r = 0.94, P < .05). CONCLUSION: Measurements from 3 baseline and 3 most recent scans preceding follow-up visit enable calculation of TVDT and can be used as predictors of mortality from MTC.
引用
- Behairy N, Leonardi AJ, Gubbi S, et al. Tumor Volume Doubling Time of Less Than 1 Year Is Associated With a Higher Risk of Death From Medullary Thyroid Cancer. J Clin Endocrinol Metab. 2025. PMID: 39412150. doi:10.1210/clinem/dgae733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。